New artificial intelligence offers hope for liver cancer patients with less than 13 percent chance of survival

Researchers at King’s College Hospital and Queen Mary University of London have shown that a new computer-based algorithm can rank drugs used to treat primary liver cancer, based on their efficacy in reducing cancer cell growth.

This post was originally published on this site